- Home
- NKTX vs ICAD Comparison
NKTX vs ICAD Comparison
Compare NKTX & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- ICAD
- Stock Information
- Founded
- NKTX 2015
- ICAD 1984
- Country
- NKTX United States
- ICAD United States
- Employees
- NKTX N/A
- ICAD N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- ICAD Medical/Dental Instruments
- Sector
- NKTX Health Care
- ICAD Health Care
- Exchange
- NKTX Nasdaq
- ICAD Nasdaq
- Market Cap
- NKTX 123.5M
- ICAD 103.3M
- IPO Year
- NKTX 2020
- ICAD 1986
- Fundamental
- Price
- NKTX $1.80
- ICAD $3.77
- Analyst Decision
- NKTX Strong Buy
- ICAD Hold
- Analyst Count
- NKTX 6
- ICAD 1
- Target Price
- NKTX $14.40
- ICAD N/A
- AVG Volume (30 Days)
- NKTX 434.5K
- ICAD 181.7K
- Earning Date
- NKTX 08-12-2025
- ICAD 08-12-2025
- Dividend Yield
- NKTX N/A
- ICAD N/A
- EPS Growth
- NKTX N/A
- ICAD N/A
- EPS
- NKTX N/A
- ICAD N/A
- Revenue
- NKTX N/A
- ICAD $19,528,000.00
- Revenue This Year
- NKTX N/A
- ICAD $3.60
- Revenue Next Year
- NKTX N/A
- ICAD N/A
- P/E Ratio
- NKTX N/A
- ICAD N/A
- Revenue Growth
- NKTX N/A
- ICAD 8.86
- 52 Week Low
- NKTX $1.31
- ICAD $1.19
- 52 Week High
- NKTX $8.23
- ICAD $4.02
- Technical
- Relative Strength Index (RSI)
- NKTX 51.45
- ICAD 57.70
- Support Level
- NKTX $1.68
- ICAD $3.68
- Resistance Level
- NKTX $1.84
- ICAD $3.86
- Average True Range (ATR)
- NKTX 0.08
- ICAD 0.14
- MACD
- NKTX 0.01
- ICAD -0.00
- Stochastic Oscillator
- NKTX 80.95
- ICAD 83.80
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.